Trials / Recruiting
RecruitingNCT05815628
Next-Generation-Sequencing Approach to Neutropenic Sepsis
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Boris Böll · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this prospective, observational, non-interventional, multi-centre study of the diagnostic use of DISQVER in neutropenic patients with FN is to provide further evidence of the efficacy of an NGS-based approach for detecting bloodstream infection in neutropenic patients.
Detailed description
The aim of this prospective, observational, non-interventional, multi-centre study of the diagnostic use of DISQVER (Platform for digital pathogen diagnostics from Noscendo GmbH) in neutropenic patients with FN (Febrile neutropenia) is to provide further evidence of the efficacy of an NGS (Next-generation seqzencing)-based approach for detecting bloodstream infection in neutropenic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | DISQVER | NGS based infection diagnosis |
Timeline
- Start date
- 2024-06-05
- Primary completion
- 2026-09-30
- Completion
- 2026-11-01
- First posted
- 2023-04-18
- Last updated
- 2025-08-08
Locations
6 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT05815628. Inclusion in this directory is not an endorsement.